TECHNOLOGY TRANSFER - API , FINISHED DOSAGE FORMULATION

TECHNOLOGY TRANSFER - API , FINISHED DOSAGE FORMULATION
Product Description

LICENCE OUT : GENERIC  We have a rich product portfolio of 300 products which offers the transformative treatments and life changing impacts for the patients.  The product portfolio covers the Intermediates, APIs and FDF for the technology transfer and commercialization. Feel free to contact us if you require more information from us.  Regards,  Jinjing Wang  [email protected] 

Amarantine Pharmaceutical LLC

  • US
  • 2015
    On CPHI since

Amarantine Pharmaceutical LLC

  • US
  • 2015
    On CPHI since

More Products from Amarantine Pharmaceutical LLC (2)

  • Ursodeoxycholic Acid

    Product Ursodeoxycholic Acid

    The most promising product for PSB Poised to attract greater demand in the marketAPI Finished Dosage FormulationDossier in CTD format Ready for License out
  • Dabigatran Etexilate Pellets

    Product Dabigatran Etexilate Pellets

    Amarantine Pharmaceuticals LLC offers a wide range of pellets products which includes dabigatran etexilate pellets. Contact us for more information.

Amarantine Pharmaceutical LLC resources (1)

  • Brochure API _ TEchnology Transfer

    Respected Sir/Madam,  We have promising portfolio for API. We have updated current API list. Please have a look and let us know if you would like to discuss furthet.  Additionally, I would like to emphasize on the following aspects which we can provide for efficient technology Transfer: -          Advanced Planning -          Fully Experienced Team -          Proven track record   -          Step by step Process We look forward to working with you.  Please contact us should you have any questions at all.   Regards     Jinjing Wang